The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
Accelerated approval is based on 61% overall response rate compared to 40% in control arm in the
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
This facility marks a significant milestone in transforming the global food industr
According to IQVIATM sales data for the 12-month period ending October 2024, the Vimpat Oral Solution, 10 mg/mL market achieved annual sales of approximately $57.0 million
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
SPARC to receive 55% equity in Tiller Therapeutics
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
Subscribe To Our Newsletter & Stay Updated
